Arvind Ravi, MD, PhD

Dr. Arvind Ravi is a Medical Oncologist in the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Brigham Cancer Center and Instructor in Medicine at Harvard Medical School. Dr. Ravi has an interest in advancing our understanding and treatment of genitourinary cancers including bladder cancer. His research explores the molecular underpinnings of therapy response with the goal of identifying which patients will benefit most from emerging cancer treatments including targeted therapies and immunotherapy.